Genetic Approaches to Studying Mouse Models of Human Seizure Disorders

  • Yan Yang
  • Wayne N. Frankel
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 548)

Abstract

Epilepsy, characterized by recurrent spontaneous seizures resulting from abnormal, synchronized discharges of neurons in the brain, is one of the most common neurological problems afflicting humans. Although epilepsy clearly has a large environmental component, genetics is thought to be important in the pathogenesis of at least 50% of cases.1 While common epilepsy genes have yet to be identified in humans, several genes have now been identified for rarer, monogenic epilepsies through linkage analysis or association studies followed by positional cloning.2 In parallel, the identification of candidate genes in mouse epilepsy models also facilitates the discovery of human disease genes, as shown for at least one case of idiopathic generalized epilepsy.3,4 Indeed, many features of seizures and the means by which they are induced are conserved in mammals,5 indicating common neural substrates or pathways. Mice already contribute significantly to the discovery of all the currently available antiepileptic drugs and remain a critical part of the comprehensive screening process in the search for new anticonvulsant drugs. In general, mice can provide excellent genetic models for epilepsy by permitting systematic dissection of the molecular and pathophysiologic factors that predispose to seizures in large, genetically homogenous populations.6

Keywords

Seizure Threshold Inbred Mouse Strain Juvenile Myoclonic Epilepsy Spontaneous Seizure Idiopathic Generalize Epilepsy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anderson VE, Hauser WA, Rich SS. Genetic heterogeneity and epidemiology of the epilepsies. In: Delgado-Escueta AV, Wilson WA, Olsen RW, Porter RJ, eds. Jasper’s Basic Mechanisms of the Epilepsies. Philadelphia: Lippincott Williams and Wilkins, 1999.Google Scholar
  2. 2.
    Meisler MH, Kearney J, Ottman R et al. Identification of epilepsy genes in human and mouse. Annu Rev Genet 2001; 35: 567–88.PubMedCrossRefGoogle Scholar
  3. 3.
    Burgess DL, Jones JM, Meisler MH et al. Mutation of the Cat* channel beta subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (lh) mouse. Cell 1997; 88: 385–392.PubMedCrossRefGoogle Scholar
  4. 4.
    Escayg A, De Waard M, Lee DD et al. Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet 2000; 66: 1531–1539.PubMedCrossRefGoogle Scholar
  5. 5.
    Krall RL, Penry JK, Kupferberg HJ et al. Antiepileptic drug development: I. History and a program for progress. Epilepsia 1978; 4: 393–408.CrossRefGoogle Scholar
  6. 6.
    Frankel WN. Detecting genes in new and old mouse models for epilepsy: A prospectus through the magnifying glass. Epilepsy Res 1999; 36: 97–110.CrossRefGoogle Scholar
  7. 7.
    Gusella JF, MacDonald ME. Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease. Nat Rev Neurosci 2000; 2: 109–15.CrossRefGoogle Scholar
  8. 8.
    Bronson SK, Smithies O. Altering mice by homologous recombination using embryonic stem cells. J Biol Chem 1994; 269: 27155–8.PubMedGoogle Scholar
  9. 9.
    Capecchi MR. The new mouse genetics: Altering the genome by gene targeting. Trends Genet 1989; 5: 70–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Lewandoski M. Conditional control of gene expression in the mouse. Nat Rev Genet 2001; 10: 743–55.CrossRefGoogle Scholar
  11. 11.
    Kask K, Zamanillo D, Rozov A et al. The AMPA receptor subunit G1uR-B in its Q/R site-unedited form is not essential for brain development and function. Proc Natl Acad Sci USA 1998; 95: 13777–82.PubMedCrossRefGoogle Scholar
  12. 12.
    Cossette P, Liu L, Brisebois K et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nature Genet 2002; 31: 184–189.PubMedCrossRefGoogle Scholar
  13. 13.
    Kalachikov S, Evgrafov O, Ross B et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nature Genet 2002; 30: 335–341.PubMedCrossRefGoogle Scholar
  14. 14.
    Morante-Redolat JM, Gorostidi-Pagola A, Piquer-Sirerol A et al. Mutations in the LGI1/Epitempin gene on 10824 cause autosomal dominant lateral temporal epilepsy. Hum Mol Genet 2002; 11: 1119–1128.PubMedCrossRefGoogle Scholar
  15. 15.
    Baulac S, Huberfeld G, Gourfinkel-An I et al. First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat Genet 2001; 28: 46–8.PubMedGoogle Scholar
  16. 16.
    Wallace RH, Marini C, Petrou S et al. Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 2001; 28: 49–52.PubMedGoogle Scholar
  17. 17.
    Sugawara T, Tsurubuchi Y, Agarwala KL et al. A missense mutation of the Na+ channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc Natl Acad Sci USA. 2001; 98: 6384–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Escayg A, MacDonald BT, Meisler MH et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 2000; 24: 343–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Claes L, Del-Favero J, Ceulemans B et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001; 68: 1327–32.PubMedCrossRefGoogle Scholar
  20. 20.
    Wallace RH, Wang DW, Singh R et al. Febrile seizures and generalized epilepsy associated with a mutation in the Nat-channel beta 1 subunit gene SCN1B. Nat Genet 1998; 19: 366–70.PubMedCrossRefGoogle Scholar
  21. 21.
    Singh NA, Charlier C, Stauffer D et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 1998; 18: 25–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Biervert C, Schroeder BC, Kubisch C et al. A potassium channel mutation in neonatal human epilepsy. Science 1998; 279: 403–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Charlier C, Singh NA, Ryan Sg et al. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 1998; 18: 53–5.PubMedCrossRefGoogle Scholar
  24. 24.
    Steinlein OK, Mulley JC, Propping P et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 1995; 11: 201–3.PubMedCrossRefGoogle Scholar
  25. 25.
    De Fusco M, Becchetti A, Patrignani A et al. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 2000; 26: 275–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Steinlein OK Genes and mutations in idiopathic epilepsy. Am J Med Genet 2001; 106: 139–45.Google Scholar
  27. 27.
    Jacobs MP, Fischbach GD, Davis MR et al. Future directions for epilepsy research. Neurology 2001; 57: 1536–1542.PubMedCrossRefGoogle Scholar
  28. 28.
    Dietschy JM, Turley SD. Control of cholesterol turnover in the mouse. J Biol Chem 2002; 277: 3801–3804.PubMedCrossRefGoogle Scholar
  29. 29.
    Watanabe H, Nagata E, Kosakai A et al. Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability. J Neurochem 2000; 75: 28–33.PubMedCrossRefGoogle Scholar
  30. 30.
    Noebels JL. Single locus mutations in mice expressing generalized spike-wave absence epilepsies. Ital J Neurol Sci 1995; 16: 107–11.PubMedCrossRefGoogle Scholar
  31. 31.
    Noebels JL, Sidman RL. Inherited epilepsy: spike-wave and focal motor seizures in the mutant mouse tottering. Science 1979; 204: 1334–1336.PubMedCrossRefGoogle Scholar
  32. 32.
    Cox GA, Lutz CM, Yang CL et al. Sodium/hydrogen exchanger gene defect in slow-wave epilepsy mutant mice. Cell 1997; 91: 139–48.PubMedCrossRefGoogle Scholar
  33. 33.
    Frankel WN, Taylor L, Beyer B et al. Electroconvulsive thresholds of inbred mouse strains. Genomics 2001; 74: 306–12.PubMedCrossRefGoogle Scholar
  34. 34.
    Peterson SL, Electroshock. In: Peterson SL, Albertson TE, eds. Neuropharmacology Methods in Epilepsy Research. Boca Raton: CRC Press, 1998: 1–26.Google Scholar
  35. 35.
    Ferraro TN, Golden GT, Smith GG et al. Mouse strain variation in maximal electroshock seizure threshold Brain Res 2002; 936: 82–86.Google Scholar
  36. 36.
    Kitano Y, Usui C, Takasuna K et al. Increasing-current electroshock seizure test: A new method for assessment of anti-and pro-convulsant activities of drugs in mice. J Pharmacol Toxicol Methods 1996; 35: 25–9.PubMedCrossRefGoogle Scholar
  37. 37.
    White HS, Wolf HH, Woodhead JH et al. The National Institutes of Health Anticonvulsant Drug Development Program: Screening for efficacy. Adv Neurol 1998; 76: 29–39.PubMedGoogle Scholar
  38. 38.
    Loscher W. New visions in the pharmacology of anticonvulsion. Eur J Pharmacol 1998; 342: 1–13.PubMedCrossRefGoogle Scholar
  39. 39.
    White HS. Chemoconvulsants. In: Peterson SL, Albertson TE, eds. Neuropharmacology Methods in Epilepsy Research. Boca Raton: CRC Press, 1998: 27–40.Google Scholar
  40. 40.
    Skradski SL, Clark AM, Jiang H et al. A novel gene causing a mendelian audiogenic mouse epilepsy. Neuron 2001; 31: 537–44.PubMedCrossRefGoogle Scholar
  41. 41.
    Zheng QY, Johnson KR, Erway LC. Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses. Hear Res 1999; 130: 94–107.PubMedCrossRefGoogle Scholar
  42. 42.
    Gerlai R. Gene-targeting studies of mammalian behavior: Is it the mutation or the background genotype? Trends Neurosci 1996; 19: 177–81.PubMedCrossRefGoogle Scholar
  43. 43.
    Bucan M, Abel T. The mouse: Genetics meets behavior. Nat Rev Genet 2002; 2: 114–23.CrossRefGoogle Scholar
  44. 44.
    Frankel WN. Mouse strain backgrounds: More than black and white. Neuron 1998; 20:183. 45 Schauwecker PE, Steward O. Genetic determinants of susceptibility to excitotoxic cell death: Implications for gene targeting approaches. Proc Natl Acad Sci USA 1997; 94: 4103–8.Google Scholar
  45. 46.
    Ben-Ari Y, Cossart R. Kainate, a double agent that generates seizures: Two decades of progress. Trends Neurosci 2000; 23: 580–7.PubMedCrossRefGoogle Scholar
  46. 47.
    Goelz MF, Mahler J, Harry J et al. Neuropathologic findings associated with seizures in FVB mice. Lab Anim Sci 1998; 48: 34–37.PubMedGoogle Scholar
  47. 48.
    Cox GA, Mahaffey CL, Frankel WN. Identification of the mouse neuromuscular degeneration gene and mapping of a second site suppressor allele. Neuron 1998; 1327–37.Google Scholar
  48. 49.
    Ferraro TN, Golden GT, Smith GG et al. Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice. J Neurosci 1999; 19: 6733–9.PubMedGoogle Scholar
  49. 50.
    Kosobud AE, Cross SJ, Crabbe JC. Neural sensitivity to pentylenetetrazol convulsions in inbred and selectively bred mice. Brain Res 1992; 592: 122–8.PubMedCrossRefGoogle Scholar
  50. 51.
    Ferraro TN, Golden GT, Smith GG et al. Mapping murine loci for seizure response to kainic acid. Mamm Genome 1997; 8: 200–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • Yan Yang
  • Wayne N. Frankel

There are no affiliations available

Personalised recommendations